Compounds > 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline
Page last updated: 2024-10-29

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Pulmonary Arterial Remodeling

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Pulmonary Arterial Remodeling in 2 studies

WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Pan, L1
Peng, Z1
Zhang, R2
Liang, D1
Chen, H1
Tian, H1
Wang, YC1
Cui, XB1
Chuang, YH1
Chen, SY1

Other Studies

2 other studies available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Pulmonary Arterial Remodeling

ArticleYear
JANEX-1 improves acute pulmonary embolism through VEGF and FAK in pulmonary artery smooth muscle cells.
    Experimental biology and medicine (Maywood, N.J.), 2020, Volume: 245, Issue:15

    Topics: Acute Disease; Animals; Cell Proliferation; Disease Models, Animal; Focal Adhesion Protein-Tyrosine

2020
Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling.
    Arteriosclerosis, thrombosis, and vascular biology, 2017, Volume: 37, Issue:7

    Topics: Animals; Apoptosis; Becaplermin; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Cell

2017